SCHEMBL29371925

SCHEMBL29371925

c1cc(-c2ccc(OCCN3CCCC3)cc2)c2nc(Nc3ccc(OCCN4CCCC4)cc3)ncc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.60
JAK2 O60674 5/20 0.55
JAK3 P52333 5/20 0.55
PTK2 Q05397 3/20 0.55
FGFR1 P11362 2/20 0.54
SRC P12931 10/20 0.54
YES1 P07947 4/20 0.54
KDR P35968 4/20 0.54
EPHB4 P54760 4/20 0.54
ABL1 P00519 3/20 0.54
EGFR P00533 2/20 0.54
LCK P06239 2/20 0.54
LYN P07948 2/20 0.54
CYP3A4 P08684 2/20 0.54
PDGFRB P09619 2/20 0.54
CYP2D6 P10635 2/20 0.54
CYP2C19 P33261 2/20 0.54
RAF1 P04049 1/20 0.54
FYN P06241 1/20 0.54
RPS6KB1 P23443 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18377066 1.00 BRAF (0.60) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL18377042 0.95 BRAF (0.55) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL29370829 0.95 BRAF (0.55) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL18376830 0.92 JAK2 (0.68) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL18376804 0.91 JAK2 (0.57) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL18377069 0.91 JAK2 (0.57) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL18376823 0.90 SRC (0.53) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL29371097 0.90 SRC (0.53) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL18376808 0.90 JAK2 (0.57) BRAFJAK2JAK3PTK2FGFR1
SCHEMBL18376653 0.90 JAK2 (0.57) BRAFJAK2JAK3PTK2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN disclosed